Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The significance of substance P in physiological and malignant haematopoiesis Nowicki M; Ostalska-Nowicka D; Kondraciuk B; Miskowiak BJ Clin Pathol 2007[Jul]; 60 (7): 749-55The role of substance P (SP) in physiological haematopoiesis is well established. However, it also seems to be important in the neoplastic transformation of bone marrow, leading to the development of acute leukaemia in children, and also metastases to bone marrow of solid tumours (particularly neuroblastoma and breast cancer) in early stages of these diseases. This review summarises the available data on SP involvement in both processes. In the future, SP antagonists may be used as anti-neoplastic drugs, for example by direct or indirect blocking of tumour cell proliferation through inhibition of growth factor production and interleukin-1b synthesis.|Antineoplastic Agents/pharmacology[MESH]|Bone Marrow/pathology[MESH]|Cell Transformation, Neoplastic/*metabolism[MESH]|Hematopoiesis/*physiology[MESH]|Humans[MESH]|Leukemia/metabolism[MESH]|Neoplasm Metastasis[MESH]|Neoplasm Proteins/antagonists & inhibitors/*physiology[MESH]|Neoplasms/metabolism[MESH]|Substance P/antagonists & inhibitors/*physiology[MESH]|Tachykinins/physiology[MESH] |